Development of Recombinant Toxins to Treat Hematologic Malignancies

$1,588,137ZIAFY2024CANIH

Division Of Basic Sciences - Nci

Investigators

Robert Kreitmancontact

Linked publications & trials

Paper 38851853 Paper 37059834 Paper 36546416 Paper 36108341 Paper 35026411 Paper 34535326 Paper 34202156 Paper 34030585 Paper 33754642 Paper 33627164 Paper 32109194 Paper 32077130 Paper 32040482 Paper 31992839 Paper 31665200 Paper 31628266 Paper 31099793 Paper 31068044 Paper 30577664 Paper 29742076 Paper 29072975 Paper 28983018 Paper 28436946 Paper 28087047 Paper 27903528 Paper 26614902 Paper 26556315 Paper 26520623 Paper 26350263 Paper 25728039 Paper 25700421 Paper 24931452 Paper 24799704 Paper 24697238 Paper 24578503 Paper 24277451 Paper 24097860 Paper 23347903 Paper 23233649 Paper 22753489 Paper 22730536 Paper 22355053 Paper 22210875 Paper 22180432 Paper 22068660 Paper 22003067 Paper 21917686 Paper 21813634 Paper 21764132 Paper 21599610 Paper 21599609 Paper 21599608 Paper 21504287 Paper 21463128 Paper 21436054 Paper 21410247 Paper 21368287 Paper 20872890 Paper 20687201 Paper 20215554 Paper 19821820 Paper 19814696 Paper 19745070 Paper 19689336 Paper 19671873 Paper 19414673 Paper 19344187 Paper 19188153 Paper 18988862 Paper 18596230 Paper 18431797 Paper 18295331 Paper 17462732 Paper 17059365 Paper 16794638 Paper 16681637 Paper 16675574 Paper 16311729

View original record on NIH RePORTER →